The changes in the expression levels of follicular markers in keratoacanthoma depend on the stage: Keratoacanthoma is a follicular neoplasm exhibiting infundibular/isthmic differentiation without expression of CK15

Journal of Cutaneous Pathology

Volumn 41, Issue 5, 2014, Pages 437-446

  Misago, Noriyuki ^a   Takai, Toshihiro ^b   Toda, Shuji ^a   Narisawa, Yutaka ^a  

^a SAGA UNIVERSITY   (Japan)

^b HYOGO CANCER CENTER   (Japan)

Author keywords

bulge stem cells; calretinin; cytokeratin; follicular differentiation; keratoacanthoma

Indexed keywords

CYTOKERATIN 15; TUMOR MARKER;

BIOSYNTHESIS; CANCER STAGING; CELL DIFFERENTIATION; HAIR FOLLICLE; HUMAN; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; METABOLISM; PATHOLOGY; RETROSPECTIVE STUDY; SKIN TUMOR;

CELL DIFFERENTIATION; HAIR FOLLICLE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-15; KERATOACANTHOMA; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84899547809     PISSN: 03036987     EISSN: 16000560     Source Type: Journal    
DOI: 10.1111/cup.12317     Document Type: Article

References (50)

1. Hodak E, Jones RE, Ackerman AB,. Solitary keratoacanthoma is a squamous-cell carcinoma: three examples with metastases. Am J Dermatopathol 1993; 15: 332.
2. Schwartz RA,. Keratoacanthoma. J Am Acad Dermatol 1994; 30: 1.
3. Schwartz RA,. Keratoacanthoma: a clinico-pathologic enigma. Dermatol Surg 2004; 30: 326.
4. Beham A, Regauer S, Soyer HP, Beham-Schmid C,. Keratoacanthoma: a clinically distinct variant of well differentiated squamous cell carcinoma. Adv Anat Pathol 1998; 5: 269.
5. Rook A, Whimster I,. Keratoacanthoma-a thirty year retrospect. Br J Dermatol 1979; 100: 41.
6. Sánchez Yus E, Simõn P, Requena L, Ambrojo P, de Eusebio E,. Solitary keratoacanthoma: a self-healing proliferation that frequently becomes malignant. Am J Dermatopathol 2000; 22: 305.
7. Weedon DD, Malo J, Brooks D, Williamson R,. Squamous cell carcinoma arising in keratoacanthoma: a neglected phenomenon in the elderly. Am J Dermatopathol 2010; 32: 423.
8. Ramselaar CG, Ruitenberg EJ, Kruizinga W,. Regression of induced keratoacanthomas in anagen (hair growth phase) skin grafts in mice. Cancer Res 1980; 40: 1668.
9. Ko CJ,. Keratoacanthoma: facts and controversies. Clin Dermatol 2010; 28: 254.
10. Ghadially FN,. The role of the hair follicle in the origin and evolution of some cutaneous neoplasms of man and experimental animals. Cancer 1961; 14: 801.
11. Ghadially FN, Barton BW, Kerridge DF,. The etiology of keratoacanthoma. Cancer 1963; 16: 603.
12. Ackerman AB, Mendonça AMN, Guo Y,. Keratoacanthoma vs. squamous-cell carcinoma. In, Ackerman AB, Mendonça AMN, Guo Y, eds. Differential diagnosis in dermatopathology, 2nd ed. Philaderphia/London: Lea & Febiger, 1992; 122.
13. Kossard S, Tan KB, Choy C,. Keratoacanthoma and infundibulocystic squamous cell carcinoma. Am J Dermatopathol 2008; 30: 127.
14. LeBoit PE,. Is keratoacanthoma a variant of squamous cell carcinoma. New insights into an old controversy... soon? Am J Dermatopathol 1995; 17: 319.
15. Ichikawa E, Ohnishi T, Watanabe S,. Expression of keratin and involucrin in keratoacanthoma: an immunohistochemical aid to diagnosis. J Dermatol Sci 2004; 34: 115.
16. Ito Y, Kurokawa I, Nishimura K, et al. Keratin and filaggrin expression in keratoacanthoma. J Eur Acad Dermatol Venereol 2008; 22: 353.
17. Misago N, Kimura T, Toda S, Mori T, Narisawa Y,. A revaluation of trichofolliculoma: the histopathological and immunohistochemical features. Am J Dermatopathol 2010; 32: 35.
18. Misago N, Toda S, Narisawa Y,. Tricholemmoma and clear cell squamous cell carcinoma (associated with Bowen's disease): immunohistochemical profile in comparison to normal hair follicles. Am J Dermatopathol 2012; 34: 394.
19. Misago N, Toda S, Narisawa Y,. Folliculocentric squamous cell carcinoma with tricholemmal differentiation: a reappraisal of tricholemmal carcinoma. Clin Exp Dermatol 2012; 37: 484.
20. Lyle S, Christofidou-Solomidou M, Liu Y, Elder DE, Albelda S, Cotsarelis G,. The C8/144B monoclonal antibody recognizes cytokeratin 15 and defines the location of human hair follicle stem cells. J Cell Sci 1998; 111: 3179.
21. Sellheyer K,. Stem cell markers can help identify adnexal tumor differentiation when evaluated in the context of morphology: methodology matters. J Cutan Pathol 2011; 38: 460.
22. Sellheyer K,. Basal cell carcinoma: cell of origin, cancer stem cell hypothesis and stem cell markers. Br J Dermatol 2011; 164: 696.
23. Al-Refu K,. Stem cells and alopecia: a review of pathogenesis. Br J Dermatol 2012; 167: 479.
24. Pontiggia L, Biedermann T, Meuli M, et al. Markers to evaluate the quality and self-renewing potential of engineered human skin substitutes in vitro and after transplantation. J Invest Dermatol 2009; 129: 480.
25. Poblet E, Jimenez-Acosta F, Rocamora A,. QBEND/10 (anti-CD34 antibody) in external root sheath cells and follicular tumors. J Cutan Pathol 1994; 21: 224.
26. Misago N, Toda S, Narisawa Y,. CD34 expression in human hair follicles and tricholemmoma: a comprehensive study. J Cutan Pathol 2011; 38: 609.
27. Doglioni C, Dei Tos AP, Laurino L, et al. Calretinin: a novel immunocytochemical marker for mesothelioma. Am J Surg Pathol 1996; 20: 1037.
28. Poblet E, Jimenez F, de Cabo C, Prieto-Martin A, Sánchez-Prieto R,. The calcium-binding protein calretinin is a marker of the companion cell layer of the human hair follicle. Br J Dermatol 2005; 152: 1316.
29. González-Guerra E, Requena L, Kutzner H,. Immunohistochemical study of calretinin in normal hair follicles and tumors with follicular differentiation. Actas Dermosifiliogr 2008; 99: 456.
30. González-Guerra E, Kutzner H, Rutten A, Requena L,. Immunohistochemical study of calretinin in normal skin and cutaneous adnexal proliferations. Am J Dermatopathol 2012; 34: 491.
31. Kirkham N,. Tumors and cysts of the epidermis (keratoacanthoma). In, Elder DE, ed. Lever's histopathology of the skin, 10th ed. Philaderphia: Lippincott Williams & Wilkin, 2009; 835.
32. Weedon D,. Tumors of the epidermis (keratoacanthoma). In, Weedon D, ed. Weedon's skin pathology, 3rd ed. Vol. 702. Edinburgh: Churchill Livingstone, 2010.
33. Blessing K, al Nafussi A, Gordon PM,. The regressing keratoacanthoma. Histopathology 1994; 24: 381.
34. Ko CJ, McNiff JM, Bosenberg M, Choate KA,. Keratoacanthoma: clinical and histopathologic features of regression. J Am Acad Dermatol 2012; 67: 1008.
35. Schwartz RA, Tarlow MM, Lambert WC,. Keratoacanthoma-like squamous cell carcinoma within the fibroepithelial polyp. Dermatol Surg 2004; 30: 349.
36. Arnault JP, Wechsler J, Escudier B, et al. Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib. J Clin Oncol 2009; 27: e59.
37. Misago N, Inoue T, Koba S, Narisawa Y,. Keratoacanthoma and other types of squamous cell carcinoma with crateriform architecture: classification and identification. J Dermatol 2013; 40: 443.
38. Misago N, Inoue T, Toda S, Narisawa Y,. Infundibular (follicular) and infundibulocystic squamous cell carcinoma: a clinicopathological and immunohistochemical study. Am J Dermatopathol 2011; 33: 687.
39. Misago N, Koba S, Narisawa Y,. Recurrent keratoacanthomas developing after spontaneous resolution. Acta Derm Venereol 2013; 93: 725.
40. Poblet E, Jiménez F, Godínez JM, Pascual-Martín A, Izeta A,. The immunohistochemical expression of CD34 in human hair follicles: a comparative study with the bulge marker CK15. Clin Exp Dermatol 2006; 31: 807.
41. Kloepper JE, Tiede S, Brinckmann J, et al. Immunophenotyping of the human bulge region: the quest to define useful in situ markers for human epithelial hair follicle stem cells and their niche. Exp Dermatol 2008; 17: 592.
42. Misago N, Narisawa Y,. Cytokeratin 15 expression in neoplasms with sebaceous differentiation. J Cutan Pathol 2006; 33: 634.
43. Misago N, Narisawa Y,. Cytokeratin 15 expression in apocrine mixed tumors of the skin and other benign neoplasms with apocrine differentiation. J Dermatol 2006; 33: 2.
44. Jih DM, Lyle S, Elenitsas R, Elder DE, Cotsarelis G,. Cytokeratin 15 expression in trichoepitheliomas and a subset of basal cell carcinomas suggests they originate from hair follicle stem cells. J Cutan Pathol 1999; 26: 113.
45. Kanitakis J, Bourchany D, Faure M, Claudy A,. Expression of the hair stem cell-specific keratin 15 in pilar tumors of the skin. Eur J Dermatol 1999; 9: 363.
46. Van Ruissen F, de Jongh GJ, Zeeuwen PL, Van Erp PE, Madsen P, Schalkwijk J,. Induction of normal and psoriatic phenotypes in submerged keratinocyte cultures. J Cell Physiol 1996; 168: 442.
47. Fraga GR, Prossick TA,. Tattoo-associated keratoacanthomas: a series of 8 patients with 11 keratoacanthomas. J Cutan Pathol 2010; 37: 85.
48. Ackerman AB, Reddy VB, Soyer HP, (eds). Neoplasms with follicular differentiation. New York: Ardor Scribendi, 2001; 29.
49. Cotsarelis G, Sun TT, Lavker RM,. Label-retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis. Cell 1990; 61: 1329.
50. Waseem A, Dogan B, Tidman N, et al. Keratin 15 expression in stratified epithelia: downregulation in activated keratinocytes. J Invest Dermatol 1999; 112: 362.